EPI Health Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 100

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

  • Investments
  • 1

EPI Health General Information

Description

Operator of a dermatology specialty company intended to improve patients' quality of life. The company markets prescription medicines to dermatologists for patients with acne, rosacea, dermatosis and psoriasis, providing patients with a better quality of life.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 174 Meeting Street
  • Suite 200
  • Charleston, SC 29401
  • United States
Primary Industry
Distributors (Healthcare)
Other Industries
Drug Discovery
Pharmaceuticals
Acquirer
Novan.
Corporate Office
  • 174 Meeting Street
  • Suite 200
  • Charleston, SC 29401
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EPI Health Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore EPI Health‘s full profile, request access.

Request a free trial

EPI Health Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a dermatology specialty company intended to improve patients' quality of life. The company markets prescript
Distributors (Healthcare)
Charleston, SC
100 As of 2022

Paris, France
 

Rahway, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

EPI Health Competitors (21)

One of EPI Health’s 21 competitors is Sanofi, a Corporation company based in Paris, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sanofi Corporation Paris, France
Merck & Co. Corporation Rahway, NJ
Empower Pharmacy Private Debt Financed Houston, TX
Aprecia (Drug Delivery) Venture Capital-Backed Blue Ash, OH
Brinton Pharmaceuticals Private Equity-Backed Pune, India
You’re viewing 5 of 21 competitors. Get the full list »

EPI Health Patents

EPI Health Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2951725-C Stabilized oxymetazoline formulations and their uses Active 11-Jun-2014
CA-2951725-A1 Stabilized oxymetazoline formulations and their uses Active 11-Jun-2014
EP-3154517-B1 Stabilized oxymetazoline formulations and their uses Active 11-Jun-2014
EP-3154517-B8 Stabilized oxymetazoline formulations and their uses Active 11-Jun-2014
EP-3154517-A1 Stabilized oxymetazoline formulations and their uses Active 11-Jun-2014 A61K31/4164
To view EPI Health’s complete patent history, request access »

EPI Health Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EPI Health Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore EPI Health‘s full profile, request access.

Request a free trial

EPI Health Investments (1)

EPI Health’s most recent deal was a Corporate Asset Purchase with EPI Health (Global Rights to the Rosacea Treatment RHOFADE) for . The deal was made on 10-Oct-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
EPI Health (Global Rights to the Rosacea Treatment RHOFADE) 10-Oct-2019 Corporate Asset Purchase Buildings and Property
To view EPI Health’s complete investments history, request access »

EPI Health Exits (1)

EPI Health’s most recent exit was on 10-Oct-2019 from EPI Health (Global Rights to the Rosacea Treatment RHOFADE). The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
EPI Health (Global Rights to the Rosacea Treatment RHOFADE) 10-Oct-2019 Completed
To view EPI Health’s complete exits history, request access »

EPI Health FAQs

  • When was EPI Health founded?

    EPI Health was founded in 1997.

  • Where is EPI Health headquartered?

    EPI Health is headquartered in Charleston, SC.

  • What is the size of EPI Health?

    EPI Health has 100 total employees.

  • What industry is EPI Health in?

    EPI Health’s primary industry is Distributors (Healthcare).

  • Is EPI Health a private or public company?

    EPI Health is a Private company.

  • What is the current valuation of EPI Health?

    The current valuation of EPI Health is .

  • What is EPI Health’s current revenue?

    The current revenue for EPI Health is .

  • How much funding has EPI Health raised over time?

    EPI Health has raised $1.61M.

  • Who are EPI Health’s investors?

    Evening Post Industries has invested in EPI Health.

  • Who are EPI Health’s competitors?

    Sanofi, Merck & Co., Empower Pharmacy, Aprecia (Drug Delivery), and Brinton Pharmaceuticals are some of the 21 competitors of EPI Health.

  • When was EPI Health acquired?

    EPI Health was acquired on 11-Mar-2022.

  • Who acquired EPI Health?

    EPI Health was acquired by Novan..

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »